Related Experiment Videos
Comparison of gentamicin assays
Therapeutic Drug Monitoring
|January 1, 1980
Summary
The new enzyme multiplied immunoassay technique (EMIT) for gentamicin offers a faster, simpler method for therapeutic drug monitoring. It provides comparable accuracy and precision to radioimmunoassay (RIA), making it a reliable alternative.
Area of Science:
- Clinical Chemistry
- Pharmacology
- Analytical Chemistry
Background:
- Gentamicin therapy requires precise monitoring to ensure efficacy and minimize toxicity.
- Radioimmunoassay (RIA) is an established method for measuring gentamicin levels.
- Enzyme multiplied immunoassay technique (EMIT) is a newer immunoassay method.
Purpose of the Study:
- To compare the reliability of a newly developed enzyme multiplied immunoassay technique (EMIT) for gentamicin with a radioimmunoassay (RIA) technique.
- To evaluate the accuracy, precision, and correlation between EMIT and RIA for gentamicin measurement.
Main Methods:
- A split sample comparison was performed on 86 serum samples from 35 patients.
- Gentamicin levels were measured using both EMIT (Gilford System 4) and RIA (Abbott Auto Log Gamma Counter).
- Statistical analysis included correlation, slope, and intercept calculations.
Main Results:
- The EMIT and RIA methods showed good correlation (r = 0.954), with a slope of 0.952 and an intercept of 0.017.
- Within-run and between-run precision were comparable for both assay systems.
- Both methods demonstrated suitability for routine therapeutic monitoring of gentamicin.
Conclusions:
- The EMIT gentamicin assay is a reliable alternative to RIA for therapeutic drug monitoring.
- EMIT offers significant advantages in speed and simplicity over RIA.
- EMIT maintains comparable accuracy and precision to established RIA procedures.